Heart Disease Clinical Trials in Chicago

Showing 241-257 of 257 trials

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

NCT00351559

This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.

Graft RejectionHeart Diseases

XDx629 participantsStarted Jan 2005

Palo Alto, California, United States • Stanford, California, United States • Chicago, Illinois, United States +10 more locations

TERMINATED2.2 miles

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

NCT00584714

The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).

Coronary Artery Disease

Point Biomedical300 participantsStarted Oct 2007

Tucson, Arizona, United States • Burlingame, California, United States • Long Beach, California, United States +36 more locations

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Heart Disease Trials in Other Cities

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

ARISE - Aggressive Reduction of Inflammation Stops Events

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

Attain StarFix™ Model 4195 Left Ventricular Lead

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Biomarkers in Acute Heart Failure

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Other Conditions in Chicago